ArticleSensors & diagnostics2024
Colorimetric nano-biosensor for low-resource settings: insulin as a model biomarker.
Article in Sensors & diagnostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects.Trends in biotechnology · 2026Review
- An Ultrasensitive Label-Free Aptasensor for Insulin Detection Assisted by Exonuclease III and 2-Aminopurine.Molecules (Basel, Switzerland) · 2026Article
- Review
- Size-Dependent Electrochemical and Morphological Properties of Magnetite Nanoparticles Adsorbed on Electrodes.ACS measurement science au · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Biomarkers provide critical molecular insights into diseases and abnormal conditions. However, detecting them at ultra-low concentrations is a challenge, particularly in areas with limited resources and access to sophisticated instruments. Our research is primarily focused on mitigating this challenge. In this report, we introduce a colorimetric immunosensor for detecting insulin, an essential hormone biomarker that regulates glucose metabolism, at picomolar concentrations using citrate-functionalized magnetic particles. This immunosensor utilizes a two-antibody sandwich immunoassay: one antibody is covalently conjugated to the nanoparticles to capture and isolate the target marker, while the other is labeled with horseradish peroxidase for colorimetric detection of insulin. We conducted comparative analyses of insulin detection in buffer, saliva, and serum samples, offering valuable analytical insights. Our findings indicate a detection limit of 10 pM, with dynamic ranges of 10 pM to 1 nM, 10 pM to 10 nM, and 50 pM to 1 nM for insulin detection in buffer solution, 2-fold diluted serum, and 20-fold diluted artificial saliva, respectively. We demonstrate the application of the color immunosensor to type 1 diabetes and healthy human serum samples. For human saliva analysis, the detection limit needs to be improved in our future studies. Overall, our study enhances biomarker analysis in biofluids through an equipment-free colorimetric method, which is particularly relevant for point-of-need applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.